Skip to content
Screener

Claritev Corporation CTEV Stock-Based Comp

Stock-Based Comp at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$15.2M+31.3%
UnitedHealth Group logo
UnitedHealth GroupUNH
$276M+40.1%
Conduent Incorporated logo
Conduent IncorporatedCNDT
$2M-60.0%
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
$5.25M-24.7%
Corvel logo
CorvelCRVL
$1.36M-4.0%
Phreesia logo
PhreesiaPHR
$13.55M-21.3%

Segments

By segment

See full
Reportable Segment$6.42M-2.4%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Depreciation49,97949,807
Amortization of intangible assets171,816171,942
Amortization of the right-of-use asset1,1221,809
Stock-based compensation14,27013,035
Deferred income taxes(56,889)(99,682)
Amortization of debt discounts and issuance costs3,1313,007
Non-cash interest expense31,97426,029
Loss on extinguishment of debt670

Item 1. Financial Statements

FAQ

What is Claritev Corporation's stock-based comp?
Claritev Corporation (CTEV) reported stock-based comp of $7.38M in Q2 2026.
How has Claritev Corporation's stock-based comp changed year-over-year?
Claritev Corporation's stock-based comp increased by 10.0% year-over-year, from $6.71M to $7.38M.
What is the long-term trend for Claritev Corporation's stock-based comp?
Over 4 years (2021 to 2025), Claritev Corporation's stock-based comp has grown at a 11.5% compound annual growth rate (CAGR), from $18.01M to $27.82M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Claritev Corporation's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude